CGRP and migraine: Neurogenic inflammation revisited

Journal of Headache and Pain

Volumn 6, Issue 2, 2005, Pages 61-70

  Geppetti, Pierangelo ^a,b   Capone, Jay Guido ^a   Trevisani, Marcello ^b   Nicoletti, Paola ^b   Zagli, Giovanni ^b   Tola, Maria Rosalia ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Calcitonin gene related peptide; Migraine; Neurogenic inflammation; Transient receptor potential vanilloid 1; Vasodilatation

Indexed keywords

1 [2 [4 (4 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N METHYLISOCHROMAN 6 CARBOXAMIDE; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; 4 (2 OXO 2,3 DIHYDROBENZOIMIDAZOL 1 YL)PIPERIDINE 1 CARBOXYLIC ACID [1 (3,5 DIBROMO 4 HYDROXYBENZYL) 2 OXO 2 (4 PHENYLPIPERAZIN 1 YL)ETHYL]AMIDE; 5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; ANTIMIGRAINE AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; ERGOTAMINE; LANEPITANT; N METHYL N (2 METHYLPHENYL) 3 NITRO 4 (2 THIAZOLYLSULFINYL)NITROBENZANILIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; OLCEGEPANT; PNU 10929; RECEPTOR BLOCKING AGENT; SB 273779; SUMATRIPTAN; TACHYKININ; UNCLASSIFIED DRUG; VOFOPITANT;

ANALGESIC ACTIVITY; ARTERY DILATATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HYPOTHESIS; MIGRAINE; NEUROGENIC INFLAMMATION; NONHUMAN; PARESTHESIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SPECIES DIFFERENCE; VASODILATATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CEREBRAL ARTERIES; HUMANS; MIGRAINE DISORDERS; NEUROGENIC INFLAMMATION; NOCICEPTORS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, SENSORY; TRPV CATION CHANNELS; VASODILATION;

EID: 18744364254     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10194-005-0153-6     Document Type: Review

References (81)

1. Geppetti P, Holzer P (1996) Neurogenic inflammation. CRC Press, Boca Raton
2. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824
3. Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 73:251-259
4. Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212
5. Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA (1995) NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 268:L263-L269
6. Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129-4136
7. Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238:S18-S22
8. Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: A crossover study. Cephalalgia 17:785-790
9. Diener HC (2003) RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia 23:183-185
10. Simone DA, Ochoa J (1991) Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 47:285-294
11. Geppetti P, Del Bianco E, Cecconi R, Tramontana M, Romani A, Theodorsson E (1992) Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro. Regul Pept 41:83-92
12. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54-56
13. Franco-Cereceda A (1991) Calcitonin gene-related peptide and human epicardial coronary arteries: Presence, release and vasodilator effects. Br J Pharmacol 102:506-510
14. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG (1985) Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094-1097
15. Quirion R, Van Rossum D, Dumont Y, St-Pierre S, Fournier A (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88-105
16. Morris HR, Panico M, Etienne T, Tippins J, Girgis SI, MacIntyre I (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746-748
17. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
18. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H (1994) Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160-1166
19. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci 84:8628-8632
20. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci 85:7763-7766
21. Mudderry PK, Ghatei MA, Spokes RA, Jonhs PM, Pierson AM, Hamid QA, Kanse S, Amara SG, Burrik JM, Legon S (1988) Differential expression of [alpha]-CGRP and [beta]-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25:195-205
22. Petermann J, Born W, Chang J, Fischer J (1987) Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem 262:542-545
23. Terenghi G (1999) Peripheral nerve regeneration and neurotrophic factors. J Anat 194:1-14
24. Struthers AD, Brown MJ, Macdonald DW, Beacham JL, Stevenson JC, Morris HR, MacIntyre I (1986) Human calcitonin gene related peptide: A potent endogenous vasodilator in man. Clin Sci (Lond) 70:389-393
25. Brain SD, Williams TJ (1989) Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol 97:77-82
26. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87:670-676
27. Katayama M, Nadel JA, Bunnett NW, Di Maria GU, Haxhiu M, Borson DB (1991) Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 12:563-567
28. Dennis T, Fournier A, St Pierre S, Quirion R (1989) Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 251:718-725
29. Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, Fukase M, Noda T, Fujita T (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol Endocrinol Metab 256:E331-E335
30. Njuki F, Nicholl CG, Howard A, Mak JC, Barnes PJ, Girgis SI, Legon S (1993) A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 85:385-388
31. Fluhmann B, Muff R, Hunziker W, Fischer JA, Born W (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206:341-347
32. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y (1996) A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271:11325-11329
33. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
34. Foord SM, Wise A, Brown J, Main MJ, Fraser NJ (1999) The N-terminus of RAMPs is a critical determinant of the glycosylation state and ligand binding of calcitonin receptor-like receptor. Biochem Soc Trans 27:535-539
35. Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420-423
36. Edvinsson L, Sams A, Jansen-Olesen I, Tajti J, Kane SA, Rutledge RZ, Koblan KS, Hill RG, Longmore J (2001) Characterisation of the effects of a nonpeptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 415:39-44
37. Aiyar N, Daines RA, Disa J, Chambers PA, Sauermelch CF, Quiniou M-J, Khandoudi N, Gout B, Douglas SA, Willette RN (2001) Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 296:768-775
38. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457
39. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U (2000) Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155-160
40. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405
41. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543
42. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957-962
43. Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985-990
44. Trevisani M, Smart D, Gunthorpe MJ, Tognetto M, Barbieri M, Campi B, Amadesi S, Gray J, Jerman JC, Brough SJ, Owen D, Smith GD, Randall AD, Harrison S, Bianchi A, Davis JB, Geppetti P (2002) Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5:546-551
45. Segond von Banchet G, Pastor A, Biskup C, Schlegel C, Benndorf K, Schaible H-G (2002) Localization of functional calcitonin gene-related peptide binding sites in a subpopulation of cultured dorsal root ganglion neurons. Neuroscience 110:131-145
46. Kawasaki H, Nuki C, Saito A, Takasaki K (1990) Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel. Brain Res 506:287-290
47. Kawasaki H, Nuki C, Saito A, Takasaki K (1990) Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J Pharmacol Exp Ther 252:403-409
48. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB (1990) Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature 344:770-773
49. Hong KW, Yoo SE, Yu SS, Lee JY, Rhim BY (1996) Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles. Am J Physiol Heart Circ Physiol 270:H317-H323
50. Gray DW, Marshall I (1992) Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107:691-696
51. Raddino R, Pela G, Manca C, Barbagallo M, D'Aloia A, Passeri M, Visioli O (1997) Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29:463-470
52. Wisskirchen FM, Burt RP, Marshall I (1998) Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br J Pharmacol 123:1673-1683
53. Aiyar N, Disa J, Stadel JM, Lysko PG (1999) Calcitonin gene-related peptide receptor independently stimulates 3pm,5pm-cyclic adenosine monophosphate and Ca2+ signaling pathways. Mol Cell Biochem 197:179-185
54. Yoshimoto R, Mitsui-Saito M, Ozaki H, Karaki H (1998) Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery. Br J Pharmacol 123:1645-1654
55. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270
56. Welch KMA (2003) Concepts of migraine headache pathogenesis: Insights into mechanisms of chronicity and new drug targets. Neurol Sci 24:S149-S153
57. De Vries P, Willems EW, Heiligers JPC, Villalon CM, Saxena PR (1998) The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors. Eur J Pharmacol 351:193-201
58. Leao AA (1951) The slow voltage variation of cortical spreading depression of activity. Electroencephalogr Clin Neurophysiol 3:315-321
59. James MF, Smith JM, Boniface SJ, Huang CLH, Leslie RA (2001) Cortical spreading depression and migraine: New insights from imaging? Trends Neurosci 24:266-271
60. Connor H, Bertin L, Gillies S, Beattie D, Ward P (1998) The GR205171 Clinical Study Group. Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine. Cephalalgia 18:392
61. Goldstein DJ, Offen WW, Klein EG, Phebus LA, Hipskind P, Johnson KW, Ryan RE Jr (2001) Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 21:102-106.
62. Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: A new target in the treatment of headache. Cephalalgia 24:611-622
63. Williamson DJ, Hargreaves RJ (2001) Neurogenic inflammation in the context of migraine. Microsc Res Tech 53:167-178
64. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187
65. Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S (1995) Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119-123
66. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61
67. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470
68. Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259-1287
69. Smith D, Hill RG, Edvinsson L, Longmore J (2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia 22:424-431
70. Humphrey PP, Bland-Ward PA, Carruthers AM, Connor HE, Feniuk W, Honey AC, Thomas M (2001) Inhibition of trigeminal nociceptive afferents by adenosine A1 receptor activation: A novel approach towards the design of new anti-migraine compounds. Cephalalgia 21:268-269
71. Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE (2002) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392-1401
72. Giffin NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287-292
73. Ennis MD, Ghazal NB, Hoffman RL, Smith MW, Schlachter SK, Lawson CF, Im WB, Pregenzer JF, Svensson KA, Lewis RA, Hall ED, Sutter DM, Harris LT, McCall RB (1998) Isochroman-6-carboxamides as highly selective 5-HT1D agonists: Potential new treatment for migraine without cardiovascular side effects. J Med Chem 41:2180-2183
74. Ramadan NM, Skljarevski V, Phebus LA, Johnson KW (2003) 5-HT1F receptor agonists in acute migraine treatment: A hypothesis. Cephalalgia 23:776-785
75. Gomez-Mancilla B, Cutler N, Leibowitz M, Spierings E, Klapper J, Diamond S, Goldstein J, Smith T, Couch J, Fleishaker J, Azie N, Blunt D (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727-732
76. Goldstein J, Roon I, Offen W, Phebus LA, Johnson KW, Schaus JM, Vanlaar T, Ferrari MD (1999) Migraine treatment with selective with 5-ht1F receptor agonist (SSOFRA) LY334370. Cephalalgia 19:318
77. Durham PL (2004) CGRP-receptor antagonists-a fresh approach to migraine therapy? N Engl J Med 350:1073-1075
78. Doods H (2001) Development of CGRP antagonists for the treatment of migraine. Curr Opin Investig Drugs 2:1261-1268
79. Kapoor K, Arulmani U, Heiligers JPC, Willems EW, Doods H, Villalon CM, Saxena PR (2003) Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur J Pharmacol 475:69-77
80. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110
81. Petersen K, Birk S, Lassen L, Kruuse C, Jonassen O, Lesko L, Olesen J (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25:139-147